These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24742370)

  • 21. Control of simultaneous movements distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism.
    Fleminger S
    Brain; 1992 Oct; 115 ( Pt 5)():1459-80. PubMed ID: 1358398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
    Silver M; Factor SA
    Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism.
    Ishikawa T; Funahashi T; Kudo J
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):579-82. PubMed ID: 11043809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting outcomes in Parkinson's disease: comparison of simple motor performance measures and The Unified Parkinson's Disease Rating Scale-III.
    Grill S; Weuve J; Weisskopf MG
    J Parkinsons Dis; 2011; 1(3):287-98. PubMed ID: 23939309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-motor symptoms may herald Parkinson's disease.
    Khoo TK; Burn DJ
    Practitioner; 2009 Sep; 253(1721):19-24, 2. PubMed ID: 19873855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
    Doty RL; Singh A; Tetrud J; Langston JW
    Ann Neurol; 1992 Jul; 32(1):97-100. PubMed ID: 1642478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
    Binder RL; Jonelis FJ
    Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease.
    Vale TC; Caramelli P; Cardoso F
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):547-53. PubMed ID: 25006209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.
    Gash DM; Rutland K; Hudson NL; Sullivan PG; Bing G; Cass WA; Pandya JD; Liu M; Choi DY; Hunter RL; Gerhardt GA; Smith CD; Slevin JT; Prince TS
    Ann Neurol; 2008 Feb; 63(2):184-92. PubMed ID: 18157908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
    Goldsmith JR; Herishanu YO; Podgaietski M; Kordysh E
    Environ Res; 1997; 73(1-2):156-61. PubMed ID: 9311541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin-induced parkinsonism: a case report.
    Perez Lloret S; Amaya M; Merello M
    Clin Neuropharmacol; 2009; 32(6):353-4. PubMed ID: 19952879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.
    Indo T; Ando K
    Arch Neurol; 1982 Aug; 39(8):494-6. PubMed ID: 7103798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric Patients on Neuroleptics: Evaluation of Parkinsonism and Quantified Assessment of Gait.
    Yahalom H; Israeli-Korn S; Linder M; Yekutieli Z; Karlinsky KT; Rubel Y; Livneh V; Fay-Karmon T; Hassin-Baer S; Yahalom G
    Clin Neuropharmacol; 2020; 43(1):1-6. PubMed ID: 31815747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.